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Abstract 
We attempt to analyze the reasons to low adult immunization from the willingness to pay 
perspective in the peri-urban setting of Kathmandu Valley where some private health facilities 
had organized Hepatitis B Vaccine Health camps in the recent past. We reason the existence of 
regulated Hepatitis B Vaccine market in Nepal and thereby utilize an open ended question to 
assess the willingness to pay of an unimmunized adult.  We justify the application of the two-part 
model in the study and further show that the socio-economic and demographic variables do not 
play significant role in explaining the low adult immunization except for age and employment. 
The result further reveals that people do not care to pay more for vaccination at present unless 
they apprehend the risk of suffering from disease with the disease specific symptoms or some 
history of chronic diseases. We argue that people exhibit time inconsistent - present biased 
preferences in immunization practices. The small preventive costs incurred to them on 
immunization today appear very large relative to the economic benefits realized tomorrow. There 
still exists asymmetric information so far as understanding the importance of the vaccine and its 
right/proper usage are concerned; a strong case of informing people to perceive vaccination as a 
preventive lifesaving shot thus becomes essential. 
JEL Codes: I12, I15, I18 
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 Background 
Few people recognize the fact that immunization is a safe, effective and simple way to 
prevent life threatening illnesses not only in children but also in adults. Immunizations 
among adults, in many cases, are found to be more than 50 % effective (Finger and 
Francis, 1998). Reports show higher rate of underutilization of vaccines among adults. In 
the US alone, millions of adults go without routine and recommended vaccinations each 
year, which leads to an estimated 40,000 to 50,000 preventable deaths, thousands of 
preventable illnesses, and $10 billion in preventable health care costs each year (TFAH, 
IDSA & RWJF, 2010).  The global policy environment and the contact with international 
agencies, type and quality of institutions, supply side dominance of vaccines (vs. demand 
side) are the major determining factors for the immunization coverage rates (Gauri and 
Khaleghian, 2002). Madhavi (2003) also substantiates this fact in the case of India 
reporting that the vaccine policy in India, rather than being determined by disease burden 
and demand, is increasingly driven by supply push, generated by industry and mediated 
by international organizations. Most vaccines, although affordable, do not induce people 
to take one unless persuaded at their doorsteps and that too at free of cost. Furthermore, 
less importance given to adult immunization; poor knowledge about safety and efficacy 
of vaccines; and lack of universal recommendations for all adults and financial 
constraints are other major causes of underutilization (Kishore et al, 2008).  
There are two strands of literature available relating adult immunization at micro level. 
The first one is related to assessing the willingness to pay (WTP) for a hypothetical 
vaccines such as HIV/AIDS and malaria in the economies with high prevalence of such 
 diseases. These studies utilize either OLS (Ordinary Least Squares) or the maximum 
likelihood estimation (MLE) basically to derive the standard demand function by asking 
dichotomous choice WTP questions [see for e.g.  Whittington et. al (2002); Whittington 
et. al. (2008); Cropper et. al. (2004)]. The second one is straightforward and not much 
researched (particularly adult immunization). They assess the factors affecting the adult's 
decision to vaccinate and primarily utilise the logistic regression analysis to make their 
inferences.  For e.g., Park et al (2013) assesses the determinants related to the lack of HB 
vaccine uptake in the general adult male population in Korea and find that lack of 
insurance, lower education and the lack of knowledge regarding the need for vaccination 
are the major determinants among others.   Their study is the only available work that 
analyze the reasons behind the HB uptake in adult population at micro level. Other papers 
study other vaccines particularly influenza vaccines [See: Nagata et al., (2011); Zheng et 
al., (2013) etc]. 
To our knowledge, there are negligible papers which assess the adult immunization of 
actual vaccines (vs. hypothetical) from the WTP Perspective.  Bloom et al. (2005) asserts 
that immunization has the potential to significantly boost economic growth by preventing 
millions of deaths every year and thereby reducing the costs of treatment and disability 
caused by infectious diseases. We believe that the analysis of  immunization from WTP 
perspective is quite important in developing economies where the actual vaccine market 
are largely regulated; health insurance system is not developed; and the imperfect 
knowledge prevails in immunization practices.   We therefore try to fulfill this gap in 
literature by utilizing WTP approach to adult immunization practices which we believe 
 will provide meaningful explanation to the low adult immunization in developing 
economies.  
Figure 1: Rationale for WTP study in Developing Countries 
 
Source: Author 
 
From the microeconomic theory point of view, the poor demand of a vaccine poses a 
constraint to access the information on revealed preference of the consumers making the 
derivation of a standard demand function problematic. Therefore the researchers try to 
estimate the WTP based on stated preferences with hypothetical choices known as 
contingent valuation method in most of the public programmes especially in 
environmental and health care services (Blumenschein et al., 2008). Most of the 
healthcare and a substantial portion of curative care in poor economies are provided by 
the public sector and therefore market only partially exists for a few goods and services. 
 Moreover, the prices of such goods and services are determined administratively or by 
the collusive monopoly of sellers/providers thus strictly restricting the choice or bidding 
capacity of the consumer. Whether in a hypothetical or an administered vaccine market 
situation, the true preference of the individuals cannot be revealed (See: Figure 1).    
HB and its Prevalence in Nepal 
 
HB is a potentially life-threatening liver infection caused by HB Virus (HBV). HBV 
infection is a major global public health problem and is one of the most infectious agents 
causing acute and chronic morbidity worldwide. About 2 billion people worldwide have 
been infected, among whom more than 350 million are chronic carriers of HBV (Shah, 
2005; Karki et. al. 2008; Ghimire et. al. 2007). WHO marked World Hepatitis Day on 28 
July 2011 for the first time and warned that more than five million will die of the viral 
hepatitis in the next ten years in South East Asian region and has already killed more 
people in the region than malaria, dengue, and HIV/AIDs combined.  
The incidence of acute HB in Nepal is low compared to other Afro-Asian countries 
(Shrestha, 2005). Karki et.al. (2008) found from the recent study conducted among 
Nepalese blood donors through the years 2001/2002-2006/2007 that the overall 
seroprevalence rates of HBV in a nationwide analysis were observed to be 0.82% with 
the prevalence rate of 0.92 % in Kathmandu alone. Similarly, Ghimire (2007) estimates 1 
percent reported case of positive HBV out of the 1200 blood samples collected from three 
major cities (Kathmandu, Biratnagar and Nepalgunj).  Each  of  Kathmandu and 
Nepalgunj accounted for 1.33% case of positive HBV from their respective blood 
 samples with Biratnagar no any case for the same. This indicates the higher prevalence of 
the HBV in urban centers of Nepal where proportionately larger number of people are at 
high risk to HBV.  
The HBV is transmitted through contact with the blood or other body fluids of an 
infected person-not through casual contact. Originally known as “serum hepatitis”, the 
acute illness causes liver inflammation, vomiting, jaundice and-rarely-death. Chronic HB 
may eventually cause cirrhosis and liver cancer-a fatal disease with very poor response to 
current chemotherapy
1
. Normally, half of all people infected with the HBV have no 
symptoms. Symptoms develop within 30-180 days of exposure to the virus. The 
symptoms are often compared to flu. Some symptoms include appetite loss, nausea and 
vomiting, itching all over the body, pain over the liver etc. among others. 
There is no specific treatment for acute HB. Care is aimed at maintaining comfort and 
adequate nutritional balance, including replacement of fluids that are lost from vomiting 
and diarrhea. Chronic HB can be treated with drugs, including interferon and anti-viral 
agents, which can help some patients. However, HB is preventable with a safe and 
effective vaccine. The vaccine can be given as either three or four separate doses, as part 
of existing routine immunization schedules. In areas where mother-to-infant spread of 
HBV is common, the first dose of vaccine should be given as soon as possible after birth 
(i.e. within 24 hours). The complete vaccine series induces protective antibody levels in 
more than 95% of infants, children and young adults. After age 40, protection following 
the primary vaccination series drops below 90%. At 60 years old, protective antibody 
 levels are achieved in only 65 to 75% of those vaccinated. Protection lasts at least 20 
years and should be life- long.
2
 People in high risks to HB include persons with high-risk 
sexual behavior; partners and household contacts of HBV infected persons; injecting drug 
users; persons who frequently require blood or blood products; recipients of solid organ 
transplantation; those at occupational risk of HBV infection, including health care 
workers; and international travelers to countries with high rates of HBV. 
Context of the Regulated Vaccine Market in Nepal  
Nepal started immunization service from the vaccination against small pox in the late 
1960s and then stepped ahead with Expanded Program on Immunization (EPI) in 1979 
(Acharya, 1988).   In Nepal, six traditional antigens were in use till 2002, and HB came in 
existence in 2004 with the support of Global Alliance for Vaccines and Immunization 
(GAVI). The National Immunization program (NIP) of the Ministry of Health, the 
successor of the EPI, is primarily   responsible for child immunization which is 
administered through local health institutions for free. On contrary, private health 
facilities cater to the demand for immunization of others who are ineligible under the 
NIP. These private institutions have to take prior approval from the Quality Control 
section at the Department of Health Services (DHS) of Ministry of Health. However, 
majority of these   institutions are being operated without the approval.  Moreover, they 
charge disproportionately higher prices for the HB vaccines despite the fact that the DHS 
has prescribed reasonably lower rates
3
. This indicates that the market for vaccine is very 
preliminary in Nepal further shrouded with Government Regulation (through price 
control) and unfair market practices by the private health facilities.   
 This study focuses on assessing the underlying factors responsible for low adult 
immunization in the peri-urban areas of Kathmandu Valley using the individual level 
information. We attempt to assess the same by applying the contingent valuation 
approach by asking an open ended WTP question for HB vaccine to the unimmunized 
adults.  We further justify the application of two-part model in this study by showing that 
there are large numbers of zero responses to the maximum WTP question and that the 
problem of selection bias does not appear in making vaccine decisions. We show that age 
and status of employment are the only significant determinants among the socio-
economic and demographic characteristics of the respondents. More importantly, we find 
that people are WTP significantly higher for immunization only when they self-report 
their poor health status evident in the form of some disease specific symptoms or some 
history of chronic disease.  We attribute this phenomenon to a time - inconsistent, present 
biased preferences of individuals with self control problems wherein the small preventive 
costs on vaccine today appear quite large to them relative to its large economic benefits 
tomorrow.  
Method 
Sampling Method 
A cross-sectional data was collected from January to February in 2011 from the peri-
urban setting of Kathmandu Valley namely Matatirtha Village Development Committee 
(as a rural set up) and Kirtipur Municipality (as the urban set up).
4
 Recently there has 
been a surge in HB vaccination health camps undertaken by some private health 
institutions in the peri-urban areas of the Kathmandu Valley. They organize such health 
 camps at regular intervals at some public place such as schools to ensure that the service 
is accessible to all those not covered under NIP but willing to vaccinate and that a 
complete dose of vaccine is received. Three wards from each of these set ups (rural and 
urban) where such heath camps were held in the recent past were randomly selected i.e. 
six wards in total
5
. This is interesting though - to see why the adult immunization is still 
lower - in spite of such frequently held health camps. We visited most of these private 
health facilities in Kathmandu and further inquired at local health facilities as well as  
few households to identify the wards where HB health camps were held recently
6
.  
Lastly, using proportionate sampling method, the desired number of samples was selected 
from the so selected wards separately.  
We determine the sample size assuming that the vaccinated household in the entire 
population was approximately 50 percent and that the unvaccinated household conversely 
as 50 percent. This is a reasonable assumption to make since our sample population 
includes people of all ages and not only our samples of interest i.e. adults in18-59 age 
group.   With such an assumption, our sample size will be the maximum and the sample 
will yield at least the desired precision with the most conservative sample size (Kothari, 
1985).
7
 We sampled a total of 184 of 615 households with 91 of 304 and 93 of 311 
households from the rural and urban areas respectively. Our unit of analysis is an 
unimmunized adult household member of 18-59 ages. Therefore, the effective number of 
observations used in our preferred specification is 321 out of total of 904 observations 
from 615 households sampled.  
  
A sampling frame was constructed with the serial number, household number and name 
of the household head in order to select the households from each ward. Thereafter using 
simple random sampling, the required number of samples was drawn from each ward. In 
case of refusal to participate in the survey or ignorance, the next household not within the 
selected sample was interviewed. The interview with the structured questionnaire was 
conducted either in the morning hour or in evening hour to make sure that all the 
members of the household were present during the interview. If someone cannot respond 
especially children, his/her parent (either mother or daughter) was requested to respond 
on their behalf. The questionnaire had two parts: Part I with questions on socioeconomic 
and demographic characteristics asked to respondents of all ages and Part II with 
questions on HB experience asked only to 18-59 adult age- group. Our inferences are 
based primarily on responses from the latter set of questions asked to adult age group.  
 WTP Question 
In our survey, we put the respondent in the role of a unitary decision-maker, asking him 
or her to maximize his own utility function (which may reflect altruistic preferences 
towards other family members), and subject to household income. This yields a stated 
demand for the vaccine that reflects the impact of the vaccine on the time spent ill by 
each family member and on his or her risk of dying, as well as the impact of the vaccine 
on the cost of treatment and productivity loss.  
Our study further takes the administered vaccine market situation as a starting point 
where, unlike the hypothetical vaccine market case, asking the dichotomous choice WTP 
question may be counterintuitive.   This is more so truer in the context of Nepal 
particularly with regards to HB vaccine market
8
. We, therefore, utilize the open ended 
WTP question since it does not require including bid value/ price as the explanatory 
variable in the model. Loomis et al (1997) finds no significant difference between the 
open-ended and dichotomous choice question formats irrespective of whether both are 
used to estimate either hypothetical or actual WTP.  
The open ended WTP question, based on contingent valuation method, administered to 
the respondents was:  
Suppose that three doses (shot) of HB Vaccine provide protection 
from HBV throughout your lifetime. What is the maximum price 
you are willing to pay for one shot of the vaccine provided?   
 
 Selection of Econometric Model 
Following Hammit and Zhou's  (2006) suggestion, we decompose the responses to the 
maximum  WTP question  into two parts where the first part predicts whether an 
individual has a non-zero WTP (herein referred to as selection equation) represented in 
the form of dichotomous variable Mi taking the value of unity in that case and zero if 
otherwise, and the second part predicts the formers' magnitude, conditional on being 
positive (herein referred to as outcome equation) which is basically represented as 
logarithmic transformation of the revealed amount (log)Wi . Let us represent this bivariate 
model as follows:  
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Xi1 and Xi2 are the covariate vectors that determine Mi and lnWi respectively.  and   are 
vectors of unknown parameter. u and v  are error terms with joint cumulative density 
functions and is assumed to have a bivariate normal distribution with mean zero, unit 
variance and correlation    and  i = 1,2,3………..N represents the individuals. A sample 
selection problem arises when the selection is on unobservables i.e.     (Cameroon 
 and Trivedi, 2005)
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. The conditional expectation of the lnWi given that Mi=1 will thus be 
given by:  
                       
          
   ............(3) 
 
where      
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 represents the inverse mills ratio which is the ratio of the 
probability density function     
    to the cumulative distribution function     
   of a 
distribution. It follows from equation (3) that the sample selection bias will be introduced 
if it is estimated using only non-zero WTP for Mi=1 since we estimate without including 
the last part on the RHS of equation (3) as one of the explanatory variables. We test the 
presence of the sample selection bias by modeling the two choices simultaneously using 
Heckman's two-step MLE method (Calia and Strazzera, 2001 & Strazzera et al., 2003b).  
Following Strazzera et al (2003a), we set up a likelihood function for the Full information 
Likelihood estimation as follows:  
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The maximization of the log-likelihood function provides sets of simultaneous equations 
of the parameters of both the outcome and the selection equations.   If we fail to reject 
null hypotheses of independence between the error terms i.e.     , then there is no 
 sample selection problem and we can use two-part model which is based on much weaker 
assumptions than the MLE since we relax the dependence of error term assumption.  
Figure 3: Choice of appropriate estimation strategy 
 
  Source: Humphreys (2013) 
 
Furthermore, the significant proportion of the people might be willing to pay nothing for 
it i.e. they choose to consume none of it which Humphreys (2013) describes as a 
"genuine zero" case.  The two part model is the appropriate model when the participation 
and consumption (herein selection and outcome equations) are independent decisions and 
that there are relatively large number of genuine zero responses (Havet et al, 2012; 
Humphery, 2013) [See Figure 3]. Furthermore, while applying the two-part model we 
compare the results from the OLS and GLM (Generalized Linear Model) estimation in 
the selection equation. The two-part model suggests running probit model in the first part 
for whether the respondents report zero or positive WTP amount and then running OLS 
 or GLM in the second part using a log-normal model only for positive WTP. GLM 
accounts for the skewness in the distribution of dependent variable and the non-linear 
effect of the predictors on the dependent variable using variance-weighing rather than 
through transformation and retransformation.   We assume gamma distribution while 
doing GLM estimation. Furthermore, we report robust standard errors clustered into 
households assuming that the observations may be correlated within households. Also we 
re-run the outcome equation in the two-part specification excluding variables that might 
be possibly correlated with each other to see if such a correlation may largely alter our 
inferences in baseline specification.  Finally, in order to check the robustness of our 
results, we run alternative specifications of OLS and Tobit Model on full sample  of  
unimmunized adults  in 18-59 age category including zero WTP responses.  
Selection of Covariates  
Following Cropper et. al.(2004), the covariates used in our study include such factors 
like, household income, household size—respondent characteristics such as age, gender, 
marital status and literacy and a vector of HB related variables indicating the health 
status. We use consumption expenditure instead of household income as a measure of 
economic well-being of the household
10
.  HB symptoms such as appetite loss, jaundice, 
liver pain etc. and HB causing activities such as blood transfusion, contact with  infected 
person, sharing needles etc. were  taken into account if they incurred in the last six 
months preceding the date of interview
11
.In order to test if people spend on HB vaccines 
if they experienced poor health from some chronic disease unrelated to HB, we also 
 include the covariate representing the prevalence of chronic disease if it happened in  the 
last one year preceding the interview date. 
Table 1: Descriptive Statistics (N=321) 
Variables Definition Mean  
WTP value (log) (N=181) Log of Positive WTP amounts  4.91 (0.95) 
Household Size  Number of member s in the household (at 
household level) 
4.67 (1.68) 
Age Completed Age in Years 37.39 (12.06) 
Age Squared Square of the completed Age in Years 1542.94 (955.39) 
Male (=1) Dummy indicating Male 0.48 (0.50) 
Married (=1) Dummy indicating married 0.80 (0.40) 
Rural (=1) Dummy indicating resident of a rural area 0.53(0.50) 
Education 
    No Education(=1) 
    Primary Education (=1) 
 
    Secondary Education (=1) 
 
    College Education (=1) 
 
Dummy indicating no schooling 
Dummy indicating Primary level  
education  completed 
Dummy indicating Secondary Level 
education  completed 
Dummy indicating College Level  
Education completed 
 
0.10 (0.30) 
 
0.19 (0.39) 
 
0.24 (0.43) 
 
0.47 (0.50) 
Employed (=1) Dummy indicating employed 0.71 (0.50) 
HB related Variables 
HB Symptoms (=1)  
 
HB Activities (=1)  
 
Chronic Disease (=1) 
 
 
Dummy indicating any or all HB 
symptoms in the last six months 
Dummy indicating any or all activities in 
the last six months that may cause HB 
Dummy indicating a chronic disease in 
the last one year 
 
 
0.02 (0.14) 
 
0.20 (0.40) 
 
0.16 (0.32) 
Consumption Expenditure  Expenditure incurred last month on 
consumption in Nepalese Rupees (at 
household level) 
13865.98 
(7282.44) 
Note: Standard Deviations are in the Parenthesis 
Source: Field Survey, 2011 
Setting Hypothesis 
The effect of household size on amount of WTP for the vaccine is unclear. Age is 
hypothesized as having positive relationship whereas the age squared with negative 
relationship with the amount of WTP for vaccine because people are WTP more when 
 they are younger since vaccines are effective during such ages but when they grow older 
they bother less about their health and also the effectiveness of vaccine declines with age 
i.e. vaccines work less effectively in old age people. This is also because older people 
probably feel less confident about their future income and have a lower opportunity cost 
of time. 
We expect that married population (=married) is more likely to pay more for the 
vaccines than the unmarried population. The simple line of reasoning would be that 
married are more responsible towards their family and therefore more health conscious 
than unmarried. The effect of gender (=male) on the probability that a respondent will 
pay more for the vaccine is also uncertain. So far as consumption expenditure is 
concerned, most studies show that higher expenditure (=consumption expenditure) are 
associated with higher WTP for healthcare. We also hypothesize the same. The effect of 
formal education is unclear. It is commonly assumed that more years of schooling would 
have a positive effect on demand for improved health, perhaps because better-educated 
people should understand better the epidemiology of the disease and the benefits derived 
from the vaccine. Education also correlates with consumption expenditure. Employment 
(=employed) is also hypothesized to have a positive effect since it correlates with both 
consumption expenditure and education. The effect of area of residence (=rural) on the 
amount of WTP is also unclear.  
We further hypothesize that the people with HB symptoms or those who have undertaken 
activities that might cause HB (=HB activities) are likely pay more to purchase the 
 vaccines than those who haven’t such symptoms or undertaken such activities. To make it 
simple, we also hypothesize that people who had had some chronic disease in the last one 
year are WTP more to buy a vaccine.  
Results  
 
The status of vaccination shows that the NIP of the Government of Nepal for children has 
been a success with about 80 percent of the respondents from the age group 1-17 already 
vaccinated. This is not the same with the older age groups where majority of the 
respondents are not vaccinated (See Table 2). This further substantiates the rationale for 
excluding the young age category 1-17 and including the adult age category 18-59 in this 
study. We further exclude the oldest age category 60+ since the vaccines are least 
effective at these ages.  The rationale for choosing 18-59 age category in the study is also 
further justified by the t-statistics for each category.  This mean vaccination decline as 
people gets older i.e. people are less willing to vaccinate with the increase in their ages.  
Table 2: Vaccination status by Age Category (t-test)
12
 
 Mean Age 
1-17 18-59 60 & 
above  
Total 
Vaccinated 
(A) 
9.98 
(82.12) 
31.70 
(43.58) 
76 
(6.56) 
21.82 
Not 
Vaccinated(B) 
9.95 
(16.79) 
37.02 
(56.42) 
69.02 
(93.44) 
37.81 
Difference (A-
B) 
0.03 -5.32*** 0.98 -15.99*** 
Source: Field Survey, 2011 
Figures in parenthesis are the percentage of respondents in the given  categories. 
 Table 3: Amount of WTP (Between 18 to 59 years) 
WTP amounts (in 
Nepalese Rs) 
Frequency (%) 
0 140 (43.6) 
0-200 69 (21.5) 
200-300 58 (18.06) 
300 & above 54 (16.84) 
Total 321 (100) 
  Source: Field Survey, 2011 
Table 3 shows that the number of people willing to pay declines with the increase in 
amount of WTP i.e. more people are WTP lesser amounts and vice versa.  Our unit of 
analysis for two-part model (WTP analysis) therefore boils down to 321 observations 
since we ignore the younger and older age groups as well those who are already 
vaccinated from the adult age group. 
We fail to reject the null hypotheses of no dependence between the error terms in 
selection and the outcome equations. MLE Heckman result shows the likelihood- ratio 
test of independent equations with the chi-square value 1.17 and the p-value of 0.2793 
(Result not shown).  This means that the selection is on observables and that there is no 
problem of selectivity bias. This also shows that there is no problem of non-randomness 
induced from the self- selected samples of unimmunized adults from 18-59 age -category.  
Three observations from the young age group (1-17) were not used in Heckman analysis 
since they could not recall their vaccination status. We also observe that about 44 percent 
of the respondents replied zero amount to maximum WTP questions as a "genuine zero" 
 described above.  As such, we use two-part model as the appropriate fit model in the 
study. We use log-linear model in the outcome equation to ensure the normal distribution 
of the positive values of WTP.  
Table 4: Estimation Result:  Two-Part Model
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Dep. Var.  Log of Positive WTP Amounts 
 
Exp. Vars. OLS GLM 
   
Household Size 0.0583 0.0499 
 (0.0433) (0.0342) 
Age 0.189*** 0.167*** 
 (0.0687) (0.0568) 
Age Squared -0.00237** -0.00207*** 
 (0.000918) (0.000759) 
Employed -0.271 -0.270* 
 (0.196) (0.149) 
Chronic Disease  0.514*** 0.440*** 
  (0.194) (0.168) 
HB Activities -0.448* -0.454* 
 (0.255) (0.239) 
HB Symptoms 1.292*** 0.937*** 
 (0.248) (0.255) 
Consumption Expenditure  -0.0000216 -0.0000145 
 (0.000015) (0.0000118) 
Constant 1.810 2.504*** 
 (1.146) (0.958) 
   
Observations 181 181 
R-squared 0.237  
   
Clustered Robust Standard errors in parentheses 
    *** p<0.01, ** p<0.05, * p<0.1 
Both OLS and GLM result show that the maximum age after which the amount of WTP 
starts declining is 40 years.  WHO (2012) also mentions that the levels of protection of 
the vaccines drops below 90% after the age of 40.  This shows that the people perceive 
 this information strongly so that they show disinterest in immunization once they reach 
40 and above. Prevalence of chronic disease and the symptoms of HB here represent the 
poor health status of the respondents which, according to our findings, means that they 
are willing to pay more when they perceive their health status as poor. However, this is 
much higher in the latter case with respondents reporting some HB symptoms - they are 
WTP about 100 percentage points more than the one without such symptoms. The 
explanation to this is obvious - the impending fear of the infection. Park et al (2013) also 
find the similar result stating that the individuals in poor health are more likely to receive 
vaccine. 
Surprisingly, the respondents reporting HB activities have a negative coefficient of 0.45 
but significant at only 10 percent level. One possible explanation to this phenomenon is 
that such activities do not directly reflect the poor health status of the people and 
therefore their wariness of being infected declines. Although this may be potentially 
linked to greater risk of infection, they do not perceive this riskiness as a direct threat to 
health.  The alternative specifications, however, show this variable as insignificant 
although  the sign is still negative (See Appendix II). 
So far as employment is concerned, GLM specification shows that it is negatively 
associated with the WTP amount at 10 percent level of significance. The opportunity cost 
of attending vaccination series for the employed individuals might be higher. This means 
they either do not account for or simply ignore the expected economic benefits from 
immunization to be realized in the future.  
 Our estimates from two-part specifications are robust to alternative OLS and Tobit 
specifications in Appendix II. However, these specifications further show that the 
consumption expenditure has a significant negative impact  on the WTP amount . We 
further checked if the possibly correlated terms in our preferred specification such as 
consumption expenditure, employment status and level of education might  render our 
estimates  inconsistent and biased. We find that the coefficients and level of significance 
for the main variables of interest does not change much from the baseline specification 
even after excluding possible correlated variables from the specification (See: Appendix 
III).  
Discussion  
Our results show that socio-economic and demographic factors do not in general 
determine the WTP for vaccines - age is shown to be the only significant predictor 
exhibiting a non-linear relationship with the amount of WTP. The inverted U shaped 
relationship imply that people are willing to pay more up to a certain years of age  
beyond which their WTP declines. We find that the maximum age at this turning point is 
40 years. This is in line with the previous researches which find that the age matters the 
most of all in making vaccine decisions. This result also coincides with the WHO 
standard prescription for HB Vaccine that its effectiveness declines after the age of 40. In 
Nepal, preventive care is still not an essential part of the household health decisions as 
compared to curative treatment and therefore people are willing to spend 
disproportionately larger amounts on the latter than former. The tendency to spend more 
by a people with the history of chronic diseases and the HB symptoms may be more 
 related to their self-control problems properly described as time inconsistent - present 
biased preferences.  
The time inconsistent preference lead people to perceive the small preventive costs on 
immunization today very large relative to the benefits typically realized far in the future. 
Dupas (2011) reasons this phenomenon for people spending huge amounts on remedial 
care whereas giving preventive tools and behaviors a far less priority at the same time. He 
, however, further substantiates that such procrastination in preventive health behavior 
becomes unlikely in the event of the health shock when suffering is immediate and risk of 
death imminent. This explains why the respondents in our study as well remain 
indifferent to immunization unless they have an impending fear of suffering - the 
suffering primarily instigated from the disease specific symptoms or some episodes of 
chronic disease not necessarily related with the vaccine preventable diseases. Several 
other papers provide an evidence of present bias justifying poor uptake of preventive 
care.   
Formal education itself does not determine adult immunization.  Dupas (2011) also puts 
forth several studies to justify that the information on health risk matter more to improve 
the preventive uptake and education is important only to help enhance information 
acquisition and learning. Our study area had seen some HB vaccination health camps in 
the recent past by private health facilities primarily targeted at the adult members. We 
expected a significant increase in adult immunization as a consequence of these camps 
but our result showed that there are still a significant number of adults unvaccinated in 
 the 18-59 age group (See Table 2). One possible explanation to this irony is the lack of 
flow of proper information about the importance of the vaccines and the health risk one is 
likely to suffer in case of adversities. The staffs from the health camps pre-visit each 
household and ask them to buy a 'coupon' for the vaccination to be held at a some pubic 
place such as schools at certain future date.  Interestingly, neither of these parties bother 
to explain or ask about the rationale for taking vaccines to each other. Hence education 
without information is not sufficient to explain the WTP of an individual.  
Above explanations on time-inconsistent preference and lack of flow of information 
indicates a huge information gap in understanding the importance of vaccination among 
adults.  It is important to inform people about the health risk and the use of vaccines as a 
preventive treatment with the enormous potential to mitigate the substantial economic 
burden in the future. 
Conclusion 
HBV is now a major global health problem primarily unfolded by the low vaccine 
coverage among the adults. This is more problematic in poor and developing countries. 
Poor economies are not well placed to cater to the basic health needs of the population - 
immunization of adults is rather a distant concern for the Government. However a 
National Campaign for adult immunization or “Immunization for all” is necessary with 
the Public-Private Partnership and should be at least made compulsory among high risk 
groups such as Health Care Providers, Commercial Sex Workers, Intravenous Drug 
Users, and Migrant Workers etc. to begin with. A strong monitoring mechanism is 
 necessary to control the unfair practice so that all the private institutions are duly 
registered with the Government and provide safer vaccines at convenient locations 
without charging exorbitant price.
                                                          
1
 Chronic diseases are diseases of long duration and generally slow progression such as heart disease, 
stroke, cancer, chronic respiratory diseases, diabetes etc. (See: 
http://www.who.int/topics/chronic_diseases/en/) 
2
 This represents the effectiveness of the vaccine. 
[http://www.wpro.who.int/mediacentre/factsheets/fs_20120219_hepb/en/] 
3
 We visited some private health facilities in Kathmandu that were involved in Hepatitis B Vaccination. 
Most of these facilities target middle class consumers and use among the cheapest vaccines available for 
sale in Nepal which is priced by Government at Nepalese Rupees 41 and Rupees 25 for adults (1 milliliter) 
and child (0.5 milliliter) respectively for one dose. We found that that most of these facilities charged prices 
which are more than 100 percent higher than the Government approved rates. Government of Nepal has 
approved to import and sale HB Vaccine of following four manufacturers: Serum Institute; L.G. Life 
Science/Shanta Biotech; and Berna Biotech (mentioned here in increasing order of the Government 
approved prices). The details of Government approved prices were obtained from Quality Control Section 
of Department of Health Services, Ministry of Health.  
4
 It might be confusing again to further divide the peri-urban setting of Kathmandu Valley into Urban and 
Rural Area (according to their administrative set up) but this will help us predict the heterogeneous effect 
of the spatial variation within the peri-urban setting on adult immunization practices.  
5
Nepal is nationally divided into 75 districts; each district further divided into Municipality and Village 
Development Committee (VDC); and each Municipality and VDC divided into wards. Ward is the lowest 
administrative level in Nepal.  
6
 We could not cross check our self reported status of vaccination from the documents of these private 
health facilities because they were reluctant to provide such details - they were concerned about their as 
well as the clients privacy.  
7
Following formula is used to determine the sample size:
qpzNe
Nqpz
n
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Where, p=sample proportion, q=1-p; Z= the value of the standard variate at a given confidence level and to 
be worked out from table showing area under normal curve;  N=Population size; e = margin of 
error/acceptable error (Precision);  n = sample size. Here, p=0.5 and q=1-p=0.05. Confidence interval 
assumed at 95% which gives z=1.96.  
8
See subsection ' Context of Regulated Vaccine Market in Nepal ' above for details on regulated Vaccine 
market in Nepal.  
9
Selection is on observables means that the error terms are dependent i.e. the outcome of interest is 
determined in part by individual choice of whether or not she participates in the activity of interest 
(Cameroon and Trivedi, 2005). 
 
10
 See:  Johnson and Shipp (1997), Haq (1998), Johnson et al (2005) etc.  
11
Symptoms develop within 30-180 days of exposure to the virus (See: 
http://www.emedicinehealth.com/hepatitis_b/) 
                                                                                                                                                                              
 
12
 The categorization of age is made according to WHO prescription of the effectiveness (protection levels) 
of HB vaccine at various ages (For details see: http://www.who.int/mediacentre/factsheets/fs204/en/). 
Furthermore, by vaccinated population, we assume that they have taken a complete three doses of vaccine. 
This assumption was important since majority of the respondents could not recall it.  
 
13
 Only estimation from second part (outcome equation) with relevant coefficients are reported. For 
complete result, see Appendix I.  
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 Appendix 
Appendix I: Estimation of the Two Part Model 
 
Dep. Var.                          Log of Positive WTP Amounts 
 
Exp. Vars. First Part  
(Probit) 
Second Part 
(OLS) 
Second Part 
(GLM) 
Household Size 0.0571 0.0583 0.0499 
 (0.0550) (0.0433) (0.0342) 
Age 0.0760 0.189*** 0.167*** 
 (0.0654) (0.0687) (0.0568) 
Age Squared -0.00144* -0.00237** -0.00207*** 
 (0.000787) (0.000918) (0.000759) 
Male 0.0599 -0.00700 0.0824 
 (0.169) (0.142) (0.122) 
Married 0.0843 -0.168 -0.175 
 (0.314) (0.260) (0.216) 
Primary Education 0.203 -0.237 -0.362 
 (0.312) (0.340) (0.266) 
Secondary Education 0.361 0.246 0.0265 
 (0.299) (0.345) (0.251) 
College Education 0.298 0.370 0.152 
 (0.364) (0.368) (0.292) 
Employed -0.208 -0.271 -0.270* 
 (0.211) (0.196) (0.149) 
Rural -0.130 -0.426 -0.263 
 (0.287) (0.260) (0.176) 
Chronic Disease 0.247 0.514*** 0.440*** 
 (0.274) (0.194) (0.168) 
HB Activities 0.0405 -0.448* -0.454* 
 (0.270) (0.255) (0.239) 
HB Symptoms 0.568 1.292*** 0.937*** 
 (0.637) (0.248) (0.255) 
Consumption Expenditure -0.0000341*** -0.0000216 -0.0000145 
 (0.0000116) (0.000015) (0.0000118) 
Constant -0.477 1.810 2.504*** 
 (1.294) (1.146) (0.958) 
    
Observations 321 181 181 
R-squared  0.237  
Cluster Robust standard errors in parentheses 
*** p<0.01, ** p<0.05, * p<0.1 
 
 Appendix II: Robustness Check with alternative Specifications 
Dep. Var. WTP Amounts 
 
Exp. Vars. OLS Tobit 
Household Size 7.317 11.55 
 (4.866) (7.764) 
Age 11.05** 28.19*** 
 (4.830) (10.21) 
Age Squared -0.166*** -0.427*** 
 (0.0571) (0.128) 
Male 9.225 16.79 
 (14.00) (25.09) 
Married 7.650 -1.117 
 (31.05) (49.63) 
Primary Education -3.834 12.35 
 (27.96) (56.05) 
Secondary Education 28.99 66.40 
 (28.26) (50.81) 
College Education 31.31 66.09 
 (34.40) (62.19) 
Employed -37.56* -57.81* 
 (19.15) (34.58) 
Rural -22.92 -48.41 
 (30.49) (49.74) 
Chronic Disease 49.50* 79.99* 
 (25.98) (45.20) 
HB Activities -39.45 -41.97 
 (27.10) (40.25) 
HB Symptoms 123.9** 168.7** 
 (51.85) (70.40) 
Consumption Expenditure -0.00220*** -0.00609*** 
 (0.000653) (0.00196) 
Constant -49.17 -329.6* 
 (90.70) (187.4) 
Observations 321 321 
R-squared 0.132  
Cluster Robust standard errors in parentheses 
    *** p<0.01, ** p<0.05, * p<0.1 
 
 
 Appendix III: Check for Possible correlated Explanatory Variables (Two-part 
Model: Second Part only) 
 
VARIABLES (Scenario 
I:excluding 
education and 
employment status) 
(Scenario II: 
excluding 
consumption and 
education) 
(Scenario III: 
excluding 
consumption and 
employment) 
Household Size 0.0691 0.0670 0.0569 
 (0.0436) (0.0435) (0.0421) 
Age 0.154** 0.139** 0.162** 
 (0.0702) (0.0652) (0.0694) 
Age Squared -0.00203** -0.00185** -0.00204** 
 (0.000940) (0.000860) (0.000931) 
Male 0.0305 0.126 -0.0894 
 (0.0855) (0.132) (0.109) 
Married -0.0988 -0.121 -0.111 
 (0.258) (0.265) (0.260) 
Rural -0.514** -0.389 -0.379 
 (0.251) (0.268) (0.271) 
Chronic Disease 0.552*** 0.550*** 0.491** 
 (0.186) (0.189) (0.201) 
HB Activities -0.493* -0.448* -0.413 
 (0.265) (0.254) (0.254) 
HB Symptoms 1.374*** 1.247*** 1.357*** 
 (0.200) (0.221) (0.213) 
Consumption Expenditure -0.0000147   
 (0.0000154)   
Employed  -0.238  
  (0.177)  
Primary Education   -0.310 
   (0.332) 
Secondary Education   0.126 
   (0.335) 
College Education   0.161 
   (0.357) 
Constant  2.585** 1.946 
 (1.094) (1.090) (1.198) 
    
Observations 181 181 181 
R-squared 0.194 0.194 0.210 
Cluster Robust standard errors in parentheses 
    *** p<0.01, ** p<0.05, * p<0.1 
